Legal Representation
Attorney
Maury M. Tepper, III
USPTO Deadlines
Application History
18 events| Date | Code | Type | Description |
|---|---|---|---|
| Jul 8, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Jul 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Jul 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Jun 22, 2025 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Jun 21, 2025 | RFRR | P | REFUSAL PROCESSED BY MPU |
| Apr 20, 2025 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Apr 19, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN |
| Apr 19, 2025 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 4, 2025 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Apr 4, 2025 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Apr 4, 2025 | ECDR | I | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Apr 4, 2025 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Apr 4, 2025 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Mar 31, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
| Mar 31, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Mar 28, 2025 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Mar 27, 2025 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
Detailed Classifications
Class 005
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 010
Medical injection devices sold empty
Additional Information
Design Mark
The mark consists of the word "VISISURE" in light blue to the right of a dark blue stylized check mark formed by an outline of the letter V.
Color Claim
The colors light blue and dark blue are claimed as a feature of the mark.
Classification
International Classes
005
010